IMDX insider transaction filings
Insight Molecular Diagnostics Inc. — 20 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-06. Screen IMDX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | Last Andrew J. — Director | Tax withholding (F): 7,700 @ $5.69 | EDGAR |
| 2026-07-06 | 4 | Arno Andrew — Director | Tax withholding (F): 12,100 @ $5.69 | EDGAR |
| 2026-07-06 | 4 | SILVERMAN LOU — Director | Tax withholding (F): 7,700 @ $5.69 | EDGAR |
| 2026-06-15 | 4 | Last Andrew J. — Director | Grant/award (A): 26,943 @ $0 | EDGAR |
| 2026-06-15 | 4 | Arno Andrew — Director | Grant/award (A): 32,331 @ $0 | EDGAR |
| 2026-06-15 | 4 | SILVERMAN LOU — Director | Grant/award (A): 26,943 @ $0 | EDGAR |
| 2026-04-27 | 4 | BROADWOOD PARTNERS, L.P. — 10% owner BROADWOOD CAPITAL INC — 10% owner Bradsher Neal C — 10% owner | Purchase (P): 280,381 @ $3.50 · Purchase (P): 0 @ $0 · Purchase (P): 38,880 @ $3.53 · Purchase (P): 0 @ $0 · Purchase (P): 250,923 @ $3.64 · Purchase (P): 0 @ $0 | EDGAR |
| 2026-04-20 | 4 | BROADWOOD PARTNERS, L.P. — 10% owner BROADWOOD CAPITAL INC — 10% owner Bradsher Neal C — 10% owner | Purchase (P): 102,057 @ $3.45 · Purchase (P): 0 @ $0 · Purchase (P): 40,114 @ $3.57 · Purchase (P): 0 @ $0 · Purchase (P): 40,690 @ $3.88 · Purchase (P): 0 @ $0 | EDGAR |
| 2026-03-30 | 4 | James Andrea S. — Chief Financial Officer | Option exercise (M): 28,302 · Tax withholding (F): 11,298 @ $4.11 · Option exercise (M): 28,302 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | Liu James Yang — VP ACCT, Cntlr, Treasurer, PAO | Option exercise (M): 6,289 · Tax withholding (F): 2,578 @ $4.11 · Option exercise (M): 6,289 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | Riggs Josh — CEO and President, Director | Option exercise (M): 47,170 · Tax withholding (F): 12,310 @ $4.11 · Option exercise (M): 47,170 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | BROADWOOD PARTNERS, L.P. — 10% owner BROADWOOD CAPITAL INC — 10% owner Bradsher Neal C — 10% owner | Purchase (P): 521,739 @ $5.75 · Purchase (P): 0 @ $0 | EDGAR |
| 2025-11-13 | 4/A | James Andrea S. — Chief Financial Officer | Option exercise (M): 50,000 @ $0 · Tax withholding (F): 12,175 @ $6.01 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | James Andrea S. — Chief Financial Officer | Option exercise (M): 50,000 @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | Liu James Yang — VP ACCT, Cntlr, Treasurer, PAO | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | James Andrea S. — Chief Financial Officer | Grant/award (A): 235,000 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | Riggs Josh — CEO and President, Director | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | Last Andrew J. — Director | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2025-07-03 | 4 | Arno Andrew — Director | Grant/award (A): 55,000 @ $0 | EDGAR |
| 2025-07-03 | 4 | SILVERMAN LOU — Director | Grant/award (A): 35,000 @ $0 | EDGAR |
Recent 8-K events — Insight Molecular Diagnostics Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K/A | 8.01 — Other Events | EDGAR |
| 2026-04-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IMDX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →